1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Varicella Vaccine
1.2.3 Influenza Vaccine
1.2.4 Polio Vaccine
1.2.5 Hepatitis A Vaccine
1.2.6 Rabies Vaccine
1.2.7 BCG Vaccine
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Others
1.3 Market by Application
1.3.1 Global Vaccine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 For Adult
1.3.3 For Child
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Vaccine Market Perspective (2016-2027)
2.2 Vaccine Growth Trends by Regions
2.2.1 Vaccine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Vaccine Historic Market Share by Regions (2016-2021)
2.2.3 Vaccine Forecasted Market Size by Regions (2022-2027)
2.3 Vaccine Industry Dynamic
2.3.1 Vaccine Market Trends
2.3.2 Vaccine Market Drivers
2.3.3 Vaccine Market Challenges
2.3.4 Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaccine Players by Revenue
3.1.1 Global Top Vaccine Players by Revenue (2016-2021)
3.1.2 Global Vaccine Revenue Market Share by Players (2016-2021)
3.2 Global Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Vaccine Revenue
3.4 Global Vaccine Market Concentration Ratio
3.4.1 Global Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccine Revenue in 2020
3.5 Vaccine Key Players Head office and Area Served
3.6 Key Players Vaccine Product Solution and Service
3.7 Date of Enter into Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccine Breakdown Data by Type
4.1 Global Vaccine Historic Market Size by Type (2016-2021)
4.2 Global Vaccine Forecasted Market Size by Type (2022-2027)
5 Vaccine Breakdown Data by Application
5.1 Global Vaccine Historic Market Size by Application (2016-2021)
5.2 Global Vaccine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Vaccine Market Size (2016-2027)
6.2 North America Vaccine Market Size by Type
6.2.1 North America Vaccine Market Size by Type (2016-2021)
6.2.2 North America Vaccine Market Size by Type (2022-2027)
6.2.3 North America Vaccine Market Size by Type (2016-2027)
6.3 North America Vaccine Market Size by Application
6.3.1 North America Vaccine Market Size by Application (2016-2021)
6.3.2 North America Vaccine Market Size by Application (2022-2027)
6.3.3 North America Vaccine Market Size by Application (2016-2027)
6.4 North America Vaccine Market Size by Country
6.4.1 North America Vaccine Market Size by Country (2016-2021)
6.4.2 North America Vaccine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Vaccine Market Size (2016-2027)
7.2 Europe Vaccine Market Size by Type
7.2.1 Europe Vaccine Market Size by Type (2016-2021)
7.2.2 Europe Vaccine Market Size by Type (2022-2027)
7.2.3 Europe Vaccine Market Size by Type (2016-2027)
7.3 Europe Vaccine Market Size by Application
7.3.1 Europe Vaccine Market Size by Application (2016-2021)
7.3.2 Europe Vaccine Market Size by Application (2022-2027)
7.3.3 Europe Vaccine Market Size by Application (2016-2027)
7.4 Europe Vaccine Market Size by Country
7.4.1 Europe Vaccine Market Size by Country (2016-2021)
7.4.2 Europe Vaccine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Vaccine Market Size (2016-2027)
8.2 Asia-Pacific Vaccine Market Size by Type
8.2.1 Asia-Pacific Vaccine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Vaccine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Vaccine Market Size by Type (2016-2027)
8.3 Asia-Pacific Vaccine Market Size by Application
8.3.1 Asia-Pacific Vaccine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Vaccine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Vaccine Market Size by Application (2016-2027)
8.4 Asia-Pacific Vaccine Market Size by Region
8.4.1 Asia-Pacific Vaccine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Vaccine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Vaccine Market Size (2016-2027)
9.2 Latin America Vaccine Market Size by Type
9.2.1 Latin America Vaccine Market Size by Type (2016-2021)
9.2.2 Latin America Vaccine Market Size by Type (2022-2027)
9.2.3 Latin America Vaccine Market Size by Type (2016-2027)
9.3 Latin America Vaccine Market Size by Application
9.3.1 Latin America Vaccine Market Size by Application (2016-2021)
9.3.2 Latin America Vaccine Market Size by Application (2022-2027)
9.3.3 Latin America Vaccine Market Size by Application (2016-2027)
9.4 Latin America Vaccine Market Size by Country
9.4.1 Latin America Vaccine Market Size by Country (2016-2021)
9.4.2 Latin America Vaccine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaccine Market Size (2016-2027)
10.2 Middle East & Africa Vaccine Market Size by Type
10.2.1 Middle East & Africa Vaccine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Vaccine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Vaccine Market Size by Type (2016-2027)
10.3 Middle East & Africa Vaccine Market Size by Application
10.3.1 Middle East & Africa Vaccine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Vaccine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Vaccine Market Size by Application (2016-2027)
10.4 Middle East & Africa Vaccine Market Size by Country
10.4.1 Middle East & Africa Vaccine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Vaccine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Vaccine Introduction
11.1.4 AstraZeneca Revenue in Vaccine Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 BioNTech
11.2.1 BioNTech Company Details
11.2.2 BioNTech Business Overview
11.2.3 BioNTech Vaccine Introduction
11.2.4 BioNTech Revenue in Vaccine Business (2016-2021)
11.2.5 BioNTech Recent Development
11.3 Boehringer-Ingelheim
11.3.1 Boehringer-Ingelheim Company Details
11.3.2 Boehringer-Ingelheim Business Overview
11.3.3 Boehringer-Ingelheim Vaccine Introduction
11.3.4 Boehringer-Ingelheim Revenue in Vaccine Business (2016-2021)
11.3.5 Boehringer-Ingelheim Recent Development
11.4 CCBIO
11.4.1 CCBIO Company Details
11.4.2 CCBIO Business Overview
11.4.3 CCBIO Vaccine Introduction
11.4.4 CCBIO Revenue in Vaccine Business (2016-2021)
11.4.5 CCBIO Recent Development
11.5 CSL
11.5.1 CSL Company Details
11.5.2 CSL Business Overview
11.5.3 CSL Vaccine Introduction
11.5.4 CSL Revenue in Vaccine Business (2016-2021)
11.5.5 CSL Recent Development
11.6 CureVac
11.6.1 CureVac Company Details
11.6.2 CureVac Business Overview
11.6.3 CureVac Vaccine Introduction
11.6.4 CureVac Revenue in Vaccine Business (2016-2021)
11.6.5 CureVac Recent Development
11.7 Elanco
11.7.1 Elanco Company Details
11.7.2 Elanco Business Overview
11.7.3 Elanco Vaccine Introduction
11.7.4 Elanco Revenue in Vaccine Business (2016-2021)
11.7.5 Elanco Recent Development
11.8 GSK
11.8.1 GSK Company Details
11.8.2 GSK Business Overview
11.8.3 GSK Vaccine Introduction
11.8.4 GSK Revenue in Vaccine Business (2016-2021)
11.8.5 GSK Recent Development
11.9 Hulan Bio
11.9.1 Hulan Bio Company Details
11.9.2 Hulan Bio Business Overview
11.9.3 Hulan Bio Vaccine Introduction
11.9.4 Hulan Bio Revenue in Vaccine Business (2016-2021)
11.9.5 Hulan Bio Recent Development
11.10 Indian Immunologicals
11.10.1 Indian Immunologicals Company Details
11.10.2 Indian Immunologicals Business Overview
11.10.3 Indian Immunologicals Vaccine Introduction
11.10.4 Indian Immunologicals Revenue in Vaccine Business (2016-2021)
11.10.5 Indian Immunologicals Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Vaccine Introduction
11.11.4 Merck Revenue in Vaccine Business (2016-2021)
11.11.5 Merck Recent Development
11.12 Minhai Biotechnology
11.12.1 Minhai Biotechnology Company Details
11.12.2 Minhai Biotechnology Business Overview
11.12.3 Minhai Biotechnology Vaccine Introduction
11.12.4 Minhai Biotechnology Revenue in Vaccine Business (2016-2021)
11.12.5 Minhai Biotechnology Recent Development
11.13 Mitsubishi Tanabe Pharma
11.13.1 Mitsubishi Tanabe Pharma Company Details
11.13.2 Mitsubishi Tanabe Pharma Business Overview
11.13.3 Mitsubishi Tanabe Pharma Vaccine Introduction
11.13.4 Mitsubishi Tanabe Pharma Revenue in Vaccine Business (2016-2021)
11.13.5 Mitsubishi Tanabe Pharma Recent Development
11.14 Moderna Therapeutics
11.14.1 Moderna Therapeutics Company Details
11.14.2 Moderna Therapeutics Business Overview
11.14.3 Moderna Therapeutics Vaccine Introduction
11.14.4 Moderna Therapeutics Revenue in Vaccine Business (2016-2021)
11.14.5 Moderna Therapeutics Recent Development
11.15 Mylan
11.15.1 Mylan Company Details
11.15.2 Mylan Business Overview
11.15.3 Mylan Vaccine Introduction
11.15.4 Mylan Revenue in Vaccine Business (2016-2021)
11.15.5 Mylan Recent Development
11.16 Plumbline Life Sciences
11.16.1 Plumbline Life Sciences Company Details
11.16.2 Plumbline Life Sciences Business Overview
11.16.3 Plumbline Life Sciences Vaccine Introduction
11.16.4 Plumbline Life Sciences Revenue in Vaccine Business (2016-2021)
11.16.5 Plumbline Life Sciences Recent Development
11.17 Sanofi
11.17.1 Sanofi Company Details
11.17.2 Sanofi Business Overview
11.17.3 Sanofi Vaccine Introduction
11.17.4 Sanofi Revenue in Vaccine Business (2016-2021)
11.17.5 Sanofi Recent Development
11.18 Translate Bio
11.18.1 Translate Bio Company Details
11.18.2 Translate Bio Business Overview
11.18.3 Translate Bio Vaccine Introduction
11.18.4 Translate Bio Revenue in Vaccine Business (2016-2021)
11.18.5 Translate Bio Recent Development
11.19 Walvax Biotechnology
11.19.1 Walvax Biotechnology Company Details
11.19.2 Walvax Biotechnology Business Overview
11.19.3 Walvax Biotechnology Vaccine Introduction
11.19.4 Walvax Biotechnology Revenue in Vaccine Business (2016-2021)
11.19.5 Walvax Biotechnology Recent Development
11.20 Wuhan Institute of Biological Products
11.20.1 Wuhan Institute of Biological Products Company Details
11.20.2 Wuhan Institute of Biological Products Business Overview
11.20.3 Wuhan Institute of Biological Products Vaccine Introduction
11.20.4 Wuhan Institute of Biological Products Revenue in Vaccine Business (2016-2021)
11.20.5 Wuhan Institute of Biological Products Recent Development
11.21 Zoties
11.21.1 Zoties Company Details
11.21.2 Zoties Business Overview
11.21.3 Zoties Vaccine Introduction
11.21.4 Zoties Revenue in Vaccine Business (2016-2021)
11.21.5 Zoties Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
